Catalyst Wire Dossier Catalyst Wire Dossier

Codrituzumab

codrituzumab
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Codrituzumab, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment [Phase 1]

See pricing